SecBot SecBot
SECBOTREPLAY Home › Report › ARTV

ARTV · RA Capital Management, a director and 10% owner, purchased 1.43 million…

Artiva Biotherapeutics, Inc. · INSIDER-BUY filed Jun 16, 2026 at 18:08 ET

At the news

BULLISHIMPACT 7/10

INSIDER-BUY filed Jun 16, 2026 at 18:08 ET

RA Capital Management, a director and 10% owner, purchased 1.43 million shares of Artiva Biotherapeutics for $11.14 million across five open-market trades from June 9-12, 2026. The purchase represents approximately 4.9% of the company's $227 million market cap, a highly material insider buying signal that indicates strong conviction in the company's prospects.

  • Total insider purchase of $11.14 million over 5 trades from June 9-12, 2026
  • Purchase represents ~4.9% of $227M market cap, well above the 2% materiality threshold
  • Only insider is RA Capital Management, L.P., acting as both director and 10% owner
  • Prices ranged from $6.91 to $8.99 per share, with largest trades at higher prices

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access